Strive files prospectus for resale of up to 1.28 billion shares on NASDAQ

Published 10/10/2025, 22:06
© Reuters

Strive, Inc. (NASDAQ:ASST), currently trading at $1.55 with a market capitalization of $141 million, announced Friday that it has filed a prospectus supplement to its existing shelf registration statement, registering the potential resale of up to 1,283,904,392 shares of its Class A common stock by certain selling securityholders. The filing was made under Form S-3 (File No. 333-290252) and relates to shares with a par value of $0.001 per share.

According to the company’s statement in the SEC filing, Strive will not receive any proceeds from the sale of these shares by the selling securityholders. The shares may be sold by the named securityholders at their discretion.

The prospectus supplement includes an opinion from Brownstein Hyatt Farber Schreck, LLP regarding the validity of the shares, which is attached as Exhibit 5.1 to the filing. A consent from the same law firm is included as Exhibit 23.1.

Strive is incorporated in Nevada and is classified under finance services. The company’s principal executive offices are located in Dallas, Texas.

This information is based on a press release statement included in Strive’s Form 8-K filed with the Securities and Exchange Commission.

In other recent news, Strive, Inc. reported preliminary financial data, revealing cash holdings of $108.6 million and ownership of 5,886 bitcoins, acquired at an average cost of $116,053 per bitcoin. The company also disclosed the sale of over 10 million shares of its Class A Common Stock, raising cash reserves for potential interest obligations and planning to issue a perpetual preferred equity security in 2025. Strive has completed its merger with Asset Entities, securing approximately $750 million in equity financing, with the potential for an additional $750 million through warrants. Additionally, Strive filed financials and pro forma data for its pending all-stock acquisition of Semler Scientific, which has been unanimously approved by both companies’ boards. In a related development, Semler Scientific secured a $20 million loan from Coinbase Credit, collateralized by Bitcoin, with a 10% interest rate and a maturity date in March 2026. Meanwhile, Strive appointed Bitcoin advocate Ben Werkman as Chief Investment Officer, who will report directly to Chairman and CEO Matt Cole. These developments highlight Strive’s strategic focus on financial growth and expansion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.